Upgrade to SI Premium - Free Trial

Truist Securities Reiterates Buy Rating on Boston Scientific (BSX)

March 30, 2026 9:13 AM
Truist Securities analyst Richard Newitter reiterated a Buy rating and $92.00 price target on Boston Scientific (NYSE: BSX).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments